Investors Encouraged to Join Class Action Against Charming Medical Limited for Securities Fraud

The Schall Law Firm, a prominent legal firm specializing in shareholder rights litigation, is calling upon investors to partake in a class action lawsuit against Charming Medical Limited (NASDAQ: MCTA). This suit stems from allegations that the company violated multiple sections of the Securities Exchange Act of 1934 as well as related regulations enforced by the U.S. Securities and Exchange Commission (SEC).

Attorney Brian Schall of the Schall Law Firm emphasizes the importance for investors who bought securities from Charming during the period from October 21 to November 12, 2025, to take immediate action before the upcoming deadline of February 17, 2026. He encourages all impacted shareholders to assess their rights and consider joining the lawsuit to seek potential recovery for their losses.

Background on the Allegations

The allegations against Charming Medical revolve around misinformation disseminated to potential investors during a volatile period for the company. In November 2025, the SEC implemented a trading suspension on Charming's shares following an unprecedented surge in stock price, a fluctuation that could not be rationalized by any company news or announcements. This sudden increase in value raised red flags, prompting investigations into possible unethical activities tied to promotional schemes.

Sources indicate that these schemes involved so-called financial advisors leveraging social media and online forums to tout the company, contributing to inflated share prices that misled the market and potential investors. As a result, it is alleged that the public statements made by Charming throughout the Class Period were both false and materially misleading, leading to severe financial repercussions for investors once the reality surfaced.

Call to Action for Affected Investors

Investors are advised to contact the Schall Law Firm to discuss eligibility to be represented in this class action lawsuit, as the class has yet to be certified. Individuals who choose not to engage in the lawsuit may remain uninvolved, which means they will not have representation. Given that the lawsuit is likely to gain traction soon, this presents a critical opportunity for any shareholders who have incurred losses due to the alleged fraudulent activities.

For further inquiries, you can reach Brian Schall directly through the firm's offices located at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, or by phone at 310-301-3335. Additionally, those interested can connect via the funeral's website at www.schallfirm.com or email them at [email protected].

Conclusion

The ongoing investigation into Charming Medical Limited highlights the potential pitfalls in stock trading and serves as a reminder for investors to remain vigilant. The Schall Law Firm's proactive approach aims to ensure that justice is served and that investors can reclaim their losses through this class action lawsuit. With the deadline for participation looming, affected investors are advised to act swiftly, emphasizing the legal support available for those affected by the company's alleged misconduct.